title: From challenges to solutions. European Bioanalysis Forum 3rd Annual Open Symposium, Hesperia Towers, Barcelona, Spain, 1-3 December 2010.
abstract: The European Bioanalysis Forum is a bioanalytical nonprofit organization comprised of European pharmaceutical companies (27 members to date) and currently expanding to include CROs as well. The European Bioanalysis Forum provides a broad European bioanalytical network for the discussion of scientific, technological and regulatory topics of bioanalytical interest. The 3rd Annual Open Symposium was again much anticipated after the two previous successful meetings. The symposium included sessions on thinking outside the 'commodity' box, bioanalytical challenges with blood, global harmonization, assay platforms, dried blood spots, immunogenicity, matrix effects, anomalous results, biomarkers and two plenary technology sessions hosted by the Platinum sponsors. Experts and key opinion leaders were invited as guest speakers. A total of 424 delegates registered from 113 companies representing a large percentage of the European bioanalytical community. In addition to 48 oral presentations, 88 posters were presented and there was a vendor exposition of 40 companies.
authors.affiliation: Shire Pharmaceuticals, Department of Biosciences, Hampshire International Business Park, Basingstoke, Hampshire RG248EP, UK. rabbott@shire.com
authors.forename: Richard W
authors.initials: RW
authors.lastname: Abbott
authors.forename: Ben
authors.initials: B
authors.lastname: Gordon
authors.forename: Peter
authors.initials: P
authors.lastname: van Amsterdam
authors.forename: Berthold
authors.initials: B
authors.lastname: Lausecker
authors.forename: Margarete
authors.initials: M
authors.lastname: Brudny-Kloeppel
authors.forename: John
authors.initials: J
authors.lastname: Smeraglia
authors.forename: Fernando
authors.initials: F
authors.lastname: Romero
authors.forename: Susanne
authors.initials: S
authors.lastname: Globig
authors.forename: Michaela
authors.initials: M
authors.lastname: Golob
authors.forename: Magnus
authors.initials: M
authors.lastname: Knutsson
authors.forename: Christian
authors.initials: C
authors.lastname: Herling
authors.forename: Eva
authors.initials: E
authors.lastname: Vieser
authors.forename: Philip
authors.initials: P
authors.lastname: Timmerman
mesh_terms: D001681:Biological Assay; D015415:Biomarkers / Q000032:analysis; D019963:Clinical Chemistry Tests / Q000379:methods* / Q000592:standards / Q000639:trends; D004345:Drug Industry; D005060:Europe; D009939:Organizations, Nonprofit; D004364:Pharmaceutical Preparations / Q000032:analysis
chemical_list: D015415:Biomarkers; D004364:Pharmaceutical Preparations